The assessment of prognosis of surgically resected oesophageal cancer is dependent on the number of lymph nodes examined pathologically

Histopathology

Volumn 55, Issue 1, 2009, Pages 46-52

  Twine, Christopher P ^a   Lewis, Wyn G ^a   Morgan, Matthew A ^a   Chan, David ^a   Clark, Geoffrey W B ^a   Havard, Tim ^b   Crosby, Tom D ^c   Roberts, S Ashley ^a   Williams, Geriant T ^c  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b ROYAL GLAMORGAN HOSPITAL   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Lymph node; Oesophageal neoplasm; Operative; Pathology; Prognosis; Surgical procedures

Indexed keywords

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; DIAGNOSTIC ERRORS; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 68049143469     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03332.x     Document Type: Article

References (41)

1. Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 2002 95 1434 1443.
2. Rizk N, Venkatraman E, Park B, Flores R, Bains MS, Rusch V. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J. Thorac. Cardiovasc. Surg. 2006 132 1374 1381.
3. Tachibana M, Yoshimura H, Kinugasa S et al. Clinicopathologic factors correlated with number of metastatic lymph nodes in oesophageal cancer. Dig. Liver Dis. 2001 33 534 538.
4. Stephens MR, Lewis WG, Brewster AE et al. Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer. Dis. Esophagus 2006 19 164 171.
5. van Vliet EP, Heijenbrok-Kal MH, Hunink MG, Kuipers EJ, Siersema PD. Staging investigations for oesophageal cancer: a meta-analysis. Br. J. Cancer 2008 98 547 557.
6. Williams GT, Quirke P, Shepherd NA. Standards and datasets for reporting cancers: dataset for colorectal cancer, 2nd edn. London : The Royal College of Pathologists, 2007.
7. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J. Natl Cancer Inst. 2007 99 433 441.
8. Quirke P, Williams GT, Ectors N, Ensari A, Piard F, Nagtegaal I. The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol. 2007 8 651 657.
9. Korst RJ, Rusch VW, Venkatraman E et al. Proposed revision of the staging classification for esophageal cancer. J. Thorac. Cardiovasc. Surg. 1998 115 660 669.
10. Lagarde SM, Reitsma JB, de Castro SM, Ten Kate FJ, Busch OR, Van Lanschot JJ. Prognostic nomogram for patients undergoing oesophagectomy for adenocarcinoma of the oesophagus or gastro-oesophageal junction. Br. J. Surg. 2007 94 1361 1368.
11. Wijnhoven BP, Tran KT, Esterman A, Watson DI, Tilanus HW. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann. Surg. 2007 245 717 725.
12. Sobin LH, Wittekind CH. TNM classification of malignant tumours, 5th edn. New York : John Wiley & Sons Inc., 2002.
13. Mapstone MP. Standards and datasets for reporting cancers: dataset for oesophageal cancer, 2nd edn. London : The Royal College of Pathologists, 2007.
14. Mariette C, Piessen G, Briez N, Triboulet JP. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann. Surg. 2008 247 365 371.
15. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958 58 457 481.
16. Cox DR. Regression models and life tables. J. Roy. Stat. Soc. 1972 34 187 200.
17. Lewis I. The surgical treatment of carcinoma of the oesophagus, with special reference to a new operation for growths of the middle third. Br. J. Surg. 1946 51 53 68.
18. Orringer MB. Transhiatal esophagectomy without thoracotomy for carcinoma of the thoracic esophagus. Ann. Surg. 1984 200 282 288.
19. Gu Y, Swisher SG, Ajani JA et al. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer 2006 106 1017 1025.
20. Kunisaki C, Akiyama H, Nomura M et al. Developing an appropriate staging system for esophageal carcinoma. J. Am. Coll. Surg. 2005 201 884 890.
21. Davies AR, Deans DA, Penman I et al. The multidisciplinary team meeting improves staging accuracy and treatment selection for gastro-esophageal cancer. Dis. Esophagus 2006 19 496 503.
22. Omloo JM, Lagarde SM, Hulscher JB et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann. Surg. 2007 246 992 1000.
23. Shimada H, Okazumi S, Matsubara H et al. Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after three-field lymph node dissection. World J. Surg. 2006 30 1441 1449.
24. Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann. Surg. Oncol. 2003 10 65 71.
25. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002 359 1727 1733.
26. Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP. Prognostic significance of the number of lymph node metastases in esophageal cancer. J. Am. Coll. Surg. 2008 206 239 246.
27. Hofstetter W, Correa AM, Bekele N et al. Proposed modification of nodal status in AJCC esophageal cancer staging system. Ann. Thorac. Surg. 2007 84 365 373.
28. Dhar DK, Hattori S, Tonomoto Y et al. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer. Ann. Thorac. Surg. 2007 83 1265 1272.
29. Bollschweiler E, Baldus SE, Schroder W, Schneider PM, Holscher AH. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors? J. Surg. Oncol. 2006 94 355 363.
30. Pedrazzani C, deManzoni G, Marrelli D et al. Nodal staging in adenocarcinoma of the gastro-esophageal junction. Proposal of a specific staging system. Ann. Surg. Oncol. 2007 14 299 305. (Pubitemid 46175269)
31. Rizk NP, Venkatraman E, Bains MS et al. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. J. Clin. Oncol. 2007 25 507 512.
32. Wilson M, Rosato EL, Chojnacki KA et al. Prognostic significance of lymph node metastases and ratio in esophageal cancer. J. Surg. Res. 2008 146 11 15.
33. Barbour AP, Rizk NP, Gonen M et al. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann. Surg. 2007 246 1 8.
34. Dutkowski P, Hommel G, Bottger T, Schlick T, Junginger T. How many lymph nodes are needed for an accurate pN classification in esophageal cancer? Evidence for a new threshold value. Hepatogastroenterology 2002 49 176 180.
35. Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J. Gastrointest. Surg. 2007 11 1384 1393.
36. Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer 2008 112 1239 1246.
37. Griffiths EA, Brummell Z, Gorthi G, Pritchard SA, Welch IM. The prognostic value of circumferential resection margin involvement in oesophageal malignancy. Eur. J. Surg. Oncol. 2006 32 413 419.
38. Khan OA, Alexiou C, Soomro I, Duffy JP, Morgan WE, Beggs FD. Pathological determinants of survival in node-negative oesophageal cancer. Br. J. Surg. 2004 91 1586 1591.
39. Khan OA, Fitzgerald JJ, Soomro I, Beggs FD, Morgan WE, Duffy JP. Prognostic significance of circumferential resection margin involvement following oesophagectomy for cancer. Br. J. Cancer 2003 88 1549 1552.
40. Dexter SP, Sue-Ling H, McMahon MJ, Quirke P, Mapstone N, Martin IG. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut 2001 48 667 670.
41. Christensen D. The Will Rogers phenomenon: roping the effects of a new cancer staging system. J. Natl Cancer Inst. 2003 95 1105 1106.